Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury.

Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, Minami T, Redondo JM, Moro MA, Cano E.

J Neuroinflammation. 2012 Mar 7;9:48. doi: 10.1186/1742-2094-9-48.

2.

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.

Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML.

Mol Pharmacol. 2011 Jun;79(6):964-73. doi: 10.1124/mol.111.071290. Epub 2011 Feb 24.

3.

Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes.

Canellada A, Ramirez BG, Minami T, Redondo JM, Cano E.

Glia. 2008 May;56(7):709-22. doi: 10.1002/glia.20647.

PMID:
18293408
4.

Kinetic properties of the redox switch/redox coupling mechanism as determined in primary cultures of cortical neurons and astrocytes from rat brain.

Ramírez BG, Rodrigues TB, Violante IR, Cruz F, Fonseca LL, Ballesteros P, Castro MM, García-Martín ML, Cerdán S.

J Neurosci Res. 2007 Nov 15;85(15):3244-53.

PMID:
17600826
5.

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML.

J Neurosci. 2005 Feb 23;25(8):1904-13.

6.

Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning.

Borcel E, Pérez-Alvarez L, de Ceballos ML, Ramirez BG, Marco EM, Fernández B, Rubio M, Guaza C, Viveros MP.

Pharmacol Biochem Behav. 2004 Jul;78(3):593-602.

PMID:
15251268

Supplemental Content

Loading ...
Support Center